- Home
- ARWR
as 11-15-2024 4:00pm EST
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
| Founded: | 2003 | Country: | United States |
| Employees: | N/A | City: | PASADENA |
| Market Cap: | 2.5B | IPO Year: | 1993 |
| Target Price: | $45.33 | AVG Volume (30 days): | 997.3K |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.66 | EPS Growth: | N/A |
| 52 Week Low/High: | $17.05 - $39.83 | Next Earning Date: | 11-26-2024 |
| Revenue: | $19,648,000 | Revenue Growth: | -92.33% |
| Revenue Growth (this year): | -68.25% | Revenue Growth (next year): | 100.95% |
Latest Arrowhead Pharmaceuticals Inc. News
ARWR Breaking Stock News: Dive into ARWR Ticker-Specific Updates for Smart Investing
Argus Research
5 days ago
ARWR: Raising target price to $23.00
Argus Research
12 days ago
ARWR: Raising target price to $22.00
Business Wire
12 days ago
Arrowhead Pharmaceuticals to Webcast 2024 Fiscal Year End Results
Business Wire
13 days ago
Arrowhead Pharmaceuticals to Participate in Upcoming November 2024 Conferences
Business Wire
16 days ago
Arrowhead Pharmaceuticals Launches New Disease Awareness Campaign, ‘We’ll Get There Soon,’ to Inspire Hope for the Rare Disease Community Affected by Familial Chylomicronemia Syndrome
GuruFocus.com
a month ago
State Street Corp's Strategic Acquisition in Arrowhead Pharmaceuticals
Business Wire
a month ago
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GuruFocus.com
a month ago
Arrowhead Pharmaceuticals Inc (ARWR) Q3 2024 Earnings Call Highlights: Navigating Financial ...
Compare ARWR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ARWR Arrowhead Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.